Acquired immunodeficiency syndrome
Conditions
Interventions
Trial group:Taiqi Peiyuan free-decocting granule (15G/time, 2 times/day) + antiretroviral treatment
Trial group:antiretroviral treatment
Sponsors
Fourth Affiliated Hospital of Xinjiang Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1) HIV antibody positive, confirmed by Western Blot; 2) age =18 years old and =60 years old; 3) RRB- syndrome of deficiency of both qi and yin; 4) voluntary and informed consent.
Exclusion criteria
Exclusion criteria: 1) those who took other immunomodulatory or related drugs during the observation period, 2) those who could not tolerate the study, and 3) those who, according to the judgment of the researchers, might interfere with the results of the trial or increase the patients' treatment risk.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| T cell ; | — |
Secondary
| Measure | Time frame |
|---|---|
| LAMP, LAMP-1, LAMP-2, GZMB;PRF1, NKG7, GNLY;Transcription factors (T-bet, Eomes, Bcl-2);Pyrosis associated proteins (HMGB1, RAGE, NLRP3, casape-1, GSDMD) mRNA;Cytokines HMGB1 and TGF- ß IL-10, IL-1 ß IL-6, TNF- a LT and IL-18; | — |
Countries
China
Contacts
Public ContactJingru Li
Fourth Affiliated Hospital of Xinjiang Medical University
Outcome results
None listed